Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof

Information

  • Patent Grant
  • 11205511
  • Patent Number
    11,205,511
  • Date Filed
    Friday, June 30, 2017
    7 years ago
  • Date Issued
    Tuesday, December 21, 2021
    2 years ago
Abstract
Methods, devices, and kits are provided for determining a compatibility of one or more devices in an analyte monitoring system.
Description
BACKGROUND

The detection of the level of glucose or other analytes, such as lactate, oxygen or the like, in certain individuals is vitally important to their health. For example, the monitoring of glucose is particularly important to individuals with diabetes. Diabetics may need to monitor glucose levels to determine when insulin is needed to reduce glucose levels in their bodies or when additional glucose is needed to raise the level of glucose in their bodies.


Devices have been developed for continuous or automatic monitoring of analytes, such as glucose, in bodily fluid such as in the blood stream or in interstitial fluid. Some of these analyte measuring devices are configured so that at least a portion of the devices are positioned below a skin surface of a user, e.g., in a blood vessel or in the subcutaneous tissue of a user.


SUMMARY

Embodiments of the present disclosure include computer-implemented methods for determining a compatibility of one or more devices in an analyte monitoring system. Certain aspects include receiving identification code data related to a configuration of a first device, retrieving information including a predetermined list of one or more acceptable identification code data that is related to one or more first device configurations that are compatible with the analyte monitoring system, comparing the received identification code data with the one or more acceptable identification codes from the retrieved predetermined list and determining if the configuration of the first device is compatible with the analyte monitoring system based upon the received identification code data being identified in the predetermined list of acceptable identification code data.


Embodiments of the present disclosure include computer-implemented methods for determining a compatibility of one or more devices in an analyte monitoring system. Certain aspects include receiving identification code data related to a configuration of a first device, retrieving information including a predetermined list of one or more identification codes that are related to one or more first device configurations and one or more software functions relating to the one or more first device configurations, comparing the received identification code data with the one or more identification codes and determining an appropriate software function for processing analyte data obtained by the first device that is related to an analyte level of a user based upon a stored software function that corresponds to the received identification code data.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 illustrates a block diagram of a data monitoring and management system for practicing one or more embodiments of the present disclosure;



FIG. 2 illustrates a data monitoring and management system for real time glucose measurement data acquisition and processing in one aspect of the present disclosure;



FIG. 3 is a block diagram of a receiver/monitor unit such as that shown in FIG. 1 in accordance with certain embodiments;



FIG. 4 is a flowchart illustrating a method for determining a compatibility of one or more devices in an analyte monitoring system in accordance with certain embodiments of the present disclosure;



FIG. 5 is a flowchart illustrating a method for determining a compatibility of one or more devices in an analyte monitoring system in accordance with certain embodiments of the present disclosure; and



FIG. 6 is a flowchart illustrating a method for determining a compatibility of one or more devices in an analyte monitoring system in accordance with certain embodiments of the present disclosure.





DETAILED DESCRIPTION

Before the present disclosure is further described, it is to be understood that this disclosure is not limited to particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present disclosure will be limited only by the appended claims.


As will be apparent to those of skill in the art upon reading this disclosure, each of the individual embodiments described and illustrated herein has discrete components and features which may be readily separated from or combined with the features of any of the other several embodiments without departing from the scope or spirit of the present disclosure.


Where a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower limit of that range and any other stated or intervening value in that stated range, is encompassed within the disclosure. The upper and lower limits of these smaller ranges may independently be included in the smaller ranges, and are also encompassed within the disclosure, subject to any specifically excluded limit in the stated range. Where the stated range includes one or both of the limits, ranges excluding either or both of those included limits are also included in the disclosure.


Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Although many methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, exemplary methods and materials are now described. All publications mentioned herein are incorporated herein by reference to disclose and describe the methods and/or materials in connection with which the publications are cited.


As used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation.


The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present disclosure is not entitled to antedate such publication by virtue of prior disclosure. Further, the dates of publication provided may be different from the actual publication dates which may need to be independently confirmed.



FIG. 1 shows a data monitoring and management system such as, for example, an analyte (e.g., glucose) monitoring system in accordance with certain embodiments of the present disclosure. Embodiments of the subject disclosure are described primarily with respect to glucose monitoring devices and systems, and methods of using two or more devices in a glucose monitoring system to determine the compatibility of one or more devices in the glucose monitoring system.


Analytes that may be monitored include, but are not limited to, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored. In those embodiments that monitor more than one analyte, the analytes may be monitored at the same or different times.


Referring to FIG. 1, the analyte monitoring system 100 includes a sensor 101, a data processing unit (e.g., sensor electronics) 102 connectable to the sensor 101, and a primary receiver unit 104 which is configured to communicate with the data processing unit 102 via a communication link 103. In aspects of the present disclosure, the sensor 101 and the data processing unit (sensor electronics) 102 may be configured as a single integrated assembly 110. In certain embodiments, the integrated sensor and sensor electronics assembly 110 may be configured as an on-body patch device. In such embodiments, the on-body patch device may be configured for, for example, RFID or RF communication with a reader device/receiver unit, and/or an insulin pump.


In certain embodiments, the primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 to evaluate or otherwise process or format data received by the primary receiver unit 104. The data processing terminal 105 may be configured to receive data directly from the data processing unit 102 via a communication link which may optionally be configured for bi-directional communication. Further, the data processing unit 102 may include a transmitter or a transceiver to transmit and/or receive data to and/or from the primary receiver unit 104, the data processing terminal 105 or optionally the secondary receiver unit 106.


Also shown in FIG. 1 is an optional secondary receiver unit 106 which is operatively coupled to the communication link and configured to receive data transmitted from the data processing unit 102. The secondary receiver unit 106 may be configured to communicate with the primary receiver unit 104, as well as the data processing terminal 105. The secondary receiver unit 106 may be configured for bi-directional wireless communication with each of the primary receiver unit 104 and the data processing terminal 105. As discussed in further detail below, in certain embodiments the secondary receiver unit 106 may be a de-featured receiver as compared to the primary receiver unit 104, i.e., the secondary receiver unit 106 may include a limited or minimal number of functions and features as compared with the primary receiver unit 104. As such, the secondary receiver unit 106 may include a smaller (in one or more, including all, dimensions), compact housing or embodied in a device such as a wrist watch, arm band, etc., for example. Alternatively, the secondary receiver unit 106 may be configured with the same or substantially similar functions and features as the primary receiver unit 104. The secondary receiver unit 106 may include a docking portion to be mated with a docking cradle unit for placement by, e.g., the bedside for night time monitoring, and/or bi-directional communication device.


Only one sensor 101, data processing unit 102 and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in FIG. 1. However, it will be appreciated by one of ordinary skill in the art that the analyte monitoring system 100 may include more than one sensor 101 and/or more than one data processing unit 102, and/or more than one data processing terminal 105.


The analyte monitoring system 100 may be a continuous monitoring system, or semi-continuous, or a discrete monitoring system. In a multi-component environment, each component may be configured to be uniquely identified by one or more of the other components in the system so that communication conflict may be readily resolved between the various components within the analyte monitoring system 100. For example, unique IDs, communication channels, and the like, may be used.


In certain embodiments, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. The sensor 101 may be configured to at least process and send data related to its configuration into a corresponding signal for transmission by the data processing unit 102.


The data processing unit 102 is coupleable to the sensor 101 so that both devices are positioned in or on the user's body, with at least a portion of the analyte sensor 101 positioned transcutaneously. The data processing unit 102 in certain embodiments may include a portion of the sensor 101 (proximal section of the sensor in electrical communication with the data processing unit 102) which is encapsulated within or on the printed circuit board of the data processing unit 102 with, for example, potting material or other protective material. The data processing unit 102 performs data processing functions, where such functions may include but are not limited to, filtering and encoding of data signals, each of which corresponds to a sampled analyte level of the user, for transmission to the primary receiver unit 104 via the communication link 103. In one embodiment, the sensor 101 or the data processing unit 102 or a combined sensor/data processing unit may be wholly implantable under the skin layer of the user.


In one aspect, the primary receiver unit 104 may include an analog interface section including an RF receiver and an antenna that is configured to communicate with the data processing unit 102 via the communication link 103, and a data processing section for processing the received data from the data processing unit 102 such as data decoding, error detection and correction, data clock generation, and/or data bit recovery.


In operation, the primary receiver unit 104 in certain embodiments is configured to synchronize with the data processing unit 102 to uniquely identify the data processing unit 102, based on, for example, identification information of the data processing unit 102, and thereafter, to periodically receive signals transmitted from the data processing unit 102 associated with the monitored analyte levels detected by the sensor 101. That is, when operating in the CGM mode, the receiver unit 104 in certain embodiments is configured to automatically receive data related to the configuration of the sensor from the analyte sensor/sensor electronics when the communication link (e.g., RF range) is maintained or opened between these components.


Referring again to FIG. 1, the data processing terminal 105 may include a personal computer, portable data processing devices or computers such as a laptop computer or a handheld device (e.g., personal digital assistants (PDAs), communication devices such as a cellular phone (e.g., a multimedia and Internet-enabled mobile phone such as an iPhone, a Blackberry device, a Palm device such as Palm Pre, Treo, or similar phone), mp3 player, pager, and the like), drug delivery device, insulin pump, each of which may be configured for data communication with the receiver via a wired or a wireless connection. Additionally, the data processing terminal 105 may further be connected to a data network (not shown).


The data processing terminal 105 may include an infusion device such as an insulin infusion pump or the like, which may be configured to administer insulin to patients, and which may be configured to communicate with the primary receiver unit 104 for receiving, among others, the measured analyte level or configuration data. Alternatively, the primary receiver unit 104 may be configured to integrate an infusion device therein so that the primary receiver unit 104 is configured to administer insulin (or other appropriate drug) therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the data processing unit 102. An infusion device may be an external device or an internal device (wholly implantable in a user).


In particular embodiments, the data processing terminal 105, which may include an insulin pump, may be configured to receive the configuration signals from the data processing unit 102, and thus, incorporate the functions of the primary receiver unit 104 including data processing for managing the patient's insulin therapy and analyte monitoring. In certain embodiments, the communication link 103 as well as one or more of the other communication interfaces shown in FIG. 1 may use one or more of an RF communication protocol, an infrared communication protocol, a Bluetooth enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per HIPPA requirements) while avoiding potential data collision and interference.


As described in aspects of the present disclosure, the analyte monitoring system may include an on-body patch device with a thin profile that can be worn on the arm or other locations on the body (and under clothing worn by the user or the patient), the on-body patch device including an analyte sensor and circuitry and components for operating the sensor and processing and storing signals, including configuration signals, received from the sensor as well as for communication with the reader device. For example, one aspect of the on-body patch device may include electronics to sample the voltage signal received from the analyte sensor in fluid contact with the body fluid, and to process the sampled voltage signals into the corresponding glucose values and/or store the sampled voltage signal as raw data, or to send configuration information as a signal or data.


In certain embodiments, the on-body patch device includes an antenna such as a loop antenna to receive RF power from an external device such as the reader device/receiver unit described above, electronics to convert the RF power received via the antenna into DC (direct current) power for the on-body patch device circuitry, communication module or electronics to detect commands received from the reader device, and communication component to transmit data to the reader device, a low capacity battery for providing power to sensor sampling circuitry (for example, the analog front end circuitry of the on-body patch device in signal communication with the analyte sensor), one or more non-volatile memory or storage devices to store data including raw signals from the sensor or processed data based on the raw sensor signals. More specifically, in the on operation demand mode, the on-body patch device in certain embodiments is configured to transmit real time analyte related data and/or stored historical analyte related data, and/or configuration data when within the RF power range of the reader device. The configuration data can be transmitted prior to transmitting the real time analyte related data.


In certain embodiments, a data processing module/terminal may be provided in the analyte monitoring system that is configured to operate as a data logger, interacting or communicating with the on-body patch device by, for example, transmitting requests for configuration information to the on-body patch device, and storing the responsive configuration information received from the on-body patch device in one or more memory components of the data processing module (e.g., repeater unit). Further, data processing module may be configured as a compact on-body relay device to relay or retransmit the received analyte level information from the on-body patch device to the reader device/receiver unit or the remote terminal or both. The data processing module in one aspect may be physically coupled to the on-body patch device, for example, on a single adhesive patch on the skin surface of the patient. Alternatively, the data processing module may be positioned close to but not in contact with the on-body patch device. For example, when the on-body patch device is positioned on the abdomen of the patient, the data processing module may be worn on a belt of the patient or the user, such that the desired close proximity or predetermined distance of approximately 1-5 inches (or about 1-10 inches, for example, or more) between the on-body patch device and the data processing module may be maintained.


The various processes described above including the processes operating in the software application execution environment in the analyte monitoring system including the on-body patch device, the reader device, data processing module and/or the remote terminal performing one or more routines described above may be embodied as computer programs developed using an object oriented language that allows the modeling of complex systems with modular objects to create abstractions that are representative of real world, physical objects and their interrelationships. The software required to carry out the inventive process, which may be stored in a memory or storage device of the storage unit of the various components of the analyte monitoring system described above in conjunction to the Figures including the on-body patch device, the reader device, the data processing module, various described communication devices, or the remote terminal may be developed by a person of ordinary skill in the art and may include one or more computer program products.


In one embodiment, an apparatus for bi-directional communication with an analyte monitoring system may comprise a storage device having stored therein one or more routines, a processing unit operatively coupled to the storage device and configured to retrieve the stored one or more routines for execution, a data transmission component operatively coupled to the processing unit and configured to transmit data based at least in part on the one or more routines executed by the processing unit, and a data reception component operatively coupled to the processing unit and configured to receive configuration data from a remote location and to store the received configuration data in the storage device for retransmission, wherein the data transmission component is programmed to transmit a query to a remote location, and further wherein the data reception component receives the configuration data from the remote location in response to the transmitted query when one or more electronics in the remote location transitions from an inactive state to an active state upon detection of the query from the data transmission component.



FIG. 2 illustrates a data monitoring and management system for device configuration related data acquisition and processing in one aspect of the present disclosure. More specifically, as shown in FIG. 2, the on-body patch device 211 including sensor electronics coupled to an analyte sensor 250 is positioned on a skin surface 210 of a patient or a user.


Referring back to FIG. 2, as shown, when the reader device/receiver unit 220 is positioned or placed in close proximity and within a predetermined range of the on-body patch device 211, the RF power supply in the reader device/receiver unit 220 may be configured to provide the necessary power to operate the electronics in the on-body patch device 211, and the on-body patch device 211 may be configured to, upon detection of the RF power from the reader device/receiver unit 220, perform preprogrammed routines including, for example, transmitting one or more signals 240 to the reader device/receiver unit 220 indicative of the configuration of the analyte sensor 250.


In certain embodiments, the reader device/receiver unit 220 may include an RF power switch that is user activatable or activated upon positioning within a predetermined distance from the on-body patch device 211 to turn on the analyte sensor in the on-body patch device 211. That is, using the RF signal, the analyte sensor coupled to the sensor electronics in the on-body patch device 211 may be initialized or activated. In another embodiment, a passive RFID function may be provided or programmed such that upon receiving a “turn on” signal which, when authenticated, will turn on the electronic power switch that activates the on-body patch device 211. That is, the passive RFID configuration may include drawing energy from the RF field radiated from the reader device/receiver unit 220 so as to prompt for and/or detect the “turn on” signal which, upon authentication, activates the on-body patch device 211.


In one embodiment, communication and/or RF power transfer between the reader device/receiver unit 220 and the on-body patch device 211 may be automatically initiated when the reader device/receiver unit 220 is placed in close proximity to the on-body patch device 211 as discussed above. Alternatively, the reader device/receiver unit 220 may be configured such that user activation, such as data request initiation and subsequent confirmation by the user using, for example, the display 222 and/or input components 221 of the reader device/receiver unit 220, may be required prior to the initiation of communication and/or RF power transfer between the reader device/receiver unit 220 and the on-body patch device 211. In a further embodiment, the reader device/receiver unit 220 may be user configurable between multiple modes, such that the user may choose whether the communication between the reader device/receiver unit 220 and on-body patch device 211 is performed automatically or requires a user activation and/or confirmation.


As further shown in FIG. 2, the display 222 of the reader device/receiver unit 220 may be configured to provide the functionalities of a user interface to present information such as alarm or alert notification to the user. In one aspect, the reader device/receiver unit 220 may include other output components such as a speaker, vibratory output component and the like to provide audible and/or vibratory output indication to the user in addition to the visual output indication provided on the display 222.


As discussed, some or all of the electronics in the on-body patch device 211 in one embodiment may be configured to rely on the RF power received from the reader device/receiver unit 220 to perform transmission of the configuration information to the reader device/receiver unit 220. That is, the on-body patch device 211 may be discreetly worn on the body of the user or the patient, and under clothing, for example, and when desired, by positioning the reader device/receiver unit 220 within a predetermined distance from the on-body patch device 211, configuration information may be received by the reader device/receiver unit 220.


Referring still to FIG. 2, also shown are a data processing module/terminal 260 and a remote terminal 270. In one aspect, data processing module 260 may include a stand alone device configured for bi-directional communication to communicate with the on-body patch device 211, the reader device/receiver unit 220 and/or the remote terminal 270. More specifically, data processing module 260 may include one or more microprocessors or similar data processing components configured to execute one or more software routines for communication, as well as data storage and retrieval to and from one or more memory components provided in the housing of the data processing module 260.


The data processing module 260 in one embodiment may be configured to communicate with the on-body patch device 211 in a similar manner as the reader device/receiver unit 220 and may include communication components such as antenna, power supply and memory, among others, for example, to allow provision of RF power to the on-body patch device 211 or to request or prompt the on-body patch device 211 to send the configuration data and optionally stored analyte related data. The data processing module 260 may be configured to interact with the on-body patch device 211 in a similar manner as the reader device/receiver unit 220 such that the data processing module 260 may be positioned within a predetermined distance from the on-body patch device 211 for communication with the on-body patch device 211.


In one aspect, the on-body patch device 211 and the data processing module 260 may be positioned on the skin surface of the user or the patient within the predetermined distance of each other (for example, within approximately 5 inches or less) such that the communication between the on-body patch device 211 and the data processing module 260 is maintained. In a further aspect, the housing of the data processing module 260 may be configured to couple to or cooperate with the housing of the on-body patch device 211 such that the two devices are combined or integrated as a single assembly and positioned on the skin surface.


Referring again to FIG. 2, the data processing module 260 may be configured or programmed to prompt or ping the on-body patch device 211 at a predetermined time interval such as upon activation of the on-body patch device 211, or once every five minutes or once every 30 minutes or any other suitable or desired programmable time interval to request configuration data from the on-body patch device 211 which is received and is stored in one or more memory devices or components of the data processing module 260. In another embodiment, the data processing module 260 is configured to prompt or ping the on-body patch device 211 when desired by the patient or the user on-demand, and not based on a predetermined time interval.


As further shown in FIG. 2, the data processing module 260 in one aspect may be configured to transmit the stored data received from the on-body patch device 211 to the reader device/receiver unit 220 when communication between the data processing module 260 and the reader device/receiver unit 220 is established. More specifically, in addition to RF antenna and RF communication components described above, data processing module 260 may include components to communicate using one or more wireless communication protocols such as, for example, but not limited to, infrared (IR) protocol, Bluetooth protocol, Zigbee protocol, and 802.11 wireless LAN protocol. Additional description of communication protocols including those based on Bluetooth protocol and/or Zigbee protocol can be found in U.S. Patent Publication No. 2006/0193375 incorporated herein by reference for all purposes. The data processing module 260 may further include communication ports, drivers or connectors to establish wired communication with one or more of the reader device/receiver unit 220, on-body patch device 211, or the remote terminal 270 including, for example, but not limited to USB connector and/or USB port, Ethernet connector and/or port, FireWire connector and/or port, or RS-232 port and/or connector.


In one aspect, the data processing module 260 may be configured to operate as a data logger configured or programmed to periodically request or prompt the on-body patch device 211 to transmit the configuration information, and to store the received information for later retrieval or subsequent transmission to the reader device/receiver unit 220 or to the remote terminal 270 or both, for further processing and analysis.


In a further aspect, the functionalities of the data processing module 260 may be configured or incorporated into a memory device such as an SD card, microSD card, compact flash card, XD card, Memory Stick card, Memory Stick Duo card, or USB memory stick/device including software programming resident in such devices to execute upon connection to the respective one or more of the on-body patch device 211, the remote terminal 270 or the reader device/receiver unit 220. In a further aspect, the functionalities of the data processing module 260, including executable software and programming, may be provided to a communication device such as a mobile telephone including, for example, iPhone, iPod Touch, Blackberry device, Palm based device (such as Palm Pre, Treo, Treo Pro, Centro), personal digital assistants (PDAs) or any other communication enabled operating system (such as Windows or Android operating systems) based mobile telephones as a downloadable application for execution by the downloading communication device. To this end, the remote terminal 270 as shown in FIG. 2 may include a personal computer, or a server terminal that is configured to provide the executable application software to the one or more of the communication devices described above when communication between the remote terminal 270 and the devices are established.


Depending upon the user setting or configuration on the communication device, the downloaded application may be programmed or customized using the user interface of the respective communication device (screen, keypad, and the like) to establish or program the desired settings such as a receiver alarm, an insulin pump alarm, sensor replacement alarm, or any other alarm or alert conditions as may be desired by the user. Moreover, the programmed notification settings on the communication device may be output using the output components of the respective communication devices, such as speaker, vibratory output component, or visual output/display. As a further example, the communication device may be provided with programming and application software to communicate with the on-body patch device 211 such that a frequency or periodicity of data acquisition is established. In this manner, the communication device may be configured to conveniently receive configuration information from the on-body patch device 211 at predetermined time periods such as, for example, but not limited to during an activation of the on-body patch device 211, once every minute, once every five minutes, or once every 10 or 15 minutes, and store the received information, as well as to provide a desired or appropriate warning indication or notification to the user or the patient.



FIG. 3 is a block diagram of a receiver/monitor unit or insulin pump such as that shown in FIG. 1 in accordance with certain embodiments. The primary receiver unit 104 (FIG. 1) includes one or more of: a blood glucose test strip interface 301, an RF receiver 302, an input 303, a temperature detection section 304, and a clock 305, each of which is operatively coupled to a processing and storage section 307. The primary receiver unit 104 also includes a power supply 306 operatively coupled to a power conversion and monitoring section 308. Further, the power conversion and monitoring section 308 is also coupled to the receiver processor 307. Moreover, also shown are a receiver serial communication section 309, and an output 310, each operatively coupled to the processing and storage unit 307. The receiver may include user input and/or interface components or may be free of user input and/or interface components.


In one aspect, the RF receiver 302 is configured to communicate, via the communication link 103 (FIG. 1) with the data processing unit (sensor electronics) 102, to receive encoded data from the data processing unit 102 for, among others, signal mixing, demodulation, and other data processing. The input 303 of the primary receiver unit 104 is configured to allow the user to enter information into the primary receiver unit 104 as needed. In one aspect, the input 303 may include keys of a keypad, a touch-sensitive screen, and/or a voice-activated input command unit, and the like. The temperature monitor section 304 may be configured to provide temperature information of the primary receiver unit 104 to the processing and control section 307, while the clock 305 provides, among others, real time or clock information to the processing and storage section 307.


Each of the various components of the primary receiver unit 104 shown in FIG. 3 is powered by the power supply 306 (or other power supply) which, in certain embodiments, includes a battery. Furthermore, the power conversion and monitoring section 308 is configured to monitor the power usage by the various components in the primary receiver unit 104 for effective power management and may alert the user, for example, in the event of power usage which renders the primary receiver unit 104 in sub-optimal operating conditions. The serial communication section 309 in the primary receiver unit 104 is configured to provide a bi-directional communication path from the testing and/or manufacturing equipment for, among others, initialization, testing, and configuration determination of the primary receiver unit 104.


Serial communication section 104 can also be used to upload data to a computer, such as configuration data. The communication link with an external device (not shown) can be made, for example, by cable (such as USB or serial cable), infrared (IR) or RF link. The output/display 310 of the primary receiver unit 104 is configured to provide, among others, a graphical user interface (GUI), and may include a liquid crystal display (LCD) for displaying information. Additionally, the output/display 310 may also include an integrated speaker for outputting audible signals as well as to provide vibration output as commonly found in handheld electronic devices, such as mobile telephones, pagers, etc. In certain embodiments, the primary receiver unit 104 also includes an electro-luminescent lamp configured to provide backlighting to the output 310 for output visual display in dark ambient surroundings.


Referring back to FIG. 3, the primary receiver unit 104 may also include a storage section such as a programmable, non-volatile memory device as part of the processor 307, or provided separately in the primary receiver unit 104, operatively coupled to the processor 307. The processor 307 may be configured to perform Manchester decoding (or other protocol(s)) as well as error detection and correction upon the encoded data received from the data processing unit 102 via the communication link 103.


In further embodiments, the data processing unit 102 and/or the primary receiver unit 104 and/or the secondary receiver unit 106, and/or the data processing terminal/infusion section 105 of FIG. 1 may be configured to receive the blood glucose value wirelessly over a communication link from, for example, a blood glucose meter. In further embodiments, a user manipulating or using the analyte monitoring system 100 (FIG. 1) may manually input the blood glucose value using, for example, a user interface (for example, a keyboard, keypad, voice commands, and the like) incorporated in the one or more of the data processing unit 102, the primary receiver unit 104, secondary receiver unit 106, or the data processing terminal/infusion section 105.


Additional detailed descriptions are provided in U.S. Pat. Nos. 5,262,035; 5,264,104; 5,262,305; 5,320,715; 5,593,852; 6,175,752; 6,650,471; 6,746, 582, 6,284,478, 7,299,082, and 7,811,231, in application Ser. No. 11/060,365, filed Feb. 16, 2005 titled “Method and System for Providing Data Communication in Continuous Glucose Monitoring And Management System”, in application Ser. No. 12/698,124, filed Feb. 1, 2010, titled “Compact On-Body Physiological Monitoring Devices and Methods Thereof”, and in application Ser. No. 12/807,278, filed Aug. 31, 2010 titled “Medical Devices and Methods”, each of which is incorporated herein by reference.


Sensors for continuous glucose monitoring systems can be continually improved and these updated versions of the sensors will be made available to consumers. An important consideration for updated sensor products is to ensure that on market system components (e.g., receiver devices, repeater units, glucose meters, insulin pumps, etc.) will work with specific components of the sensor that has been updated. Another consideration is to exclude updated components from operation with certain components if such operation is not safe and effective. For instance, some CGM algorithms may be designed to work with a particular type of sensor but not with others.


In certain embodiments, electronic system update configuration requirements can be enforced using key codes that are incorporated in the communication messages sent between system components. Sensor configuration updates can be managed using a key code technique. Since sensors themselves may not be capable of interacting with other components using key codes, such features may be integrated along with the sensor or sensor delivery system. For instance, in some embodiments, the sensor may provide a radio ID or a resistive code to indicate its configuration to the other system components. The sensor electronics (e.g., transmitter) may use these means to detect the sensor version in order to further manage component configuration (e.g., communicating the sensor version information to other components using key codes). The sensor electronics may have a range of sensor codes that it can accept, or the sensor electronics may pass the sensor code data to the receiver device (or other device in the system) that can have a range of sensor codes that it accepts. Similarly, the transmitter can have a range of acceptable receiver codes and a receiver can have a range of acceptable transmitter codes. In certain embodiments, if the receiver device detects a sensor version that is not allowable or if the transmitter sends the receiver a message indicating that the attached sensor was not allowable, it can notify the user that the sensor version is not allowable. Moreover, the transmitter and/or receiver software can change algorithms or other software functions dependent on the detected software version.


In certain embodiments, key codes can be incorporated in communication messages sent through the devices in the analyte monitoring system. Key codes are primarily available for access by electronic devices. The codes may be used as a book keeping tool to manage which version of the device may function with specific versions of a device application using a particular serial command. For example, a serial command may include a two byte key code that can be issued by a value of code=00 when it sends the command to a device. An original version of a device can be designed with a serial command function that will accept commands with a code range of 00 to 0F, for example. In this manner, if another version of the device has an updated serial command that allows a code range, e.g., of 00 to 1F, then the original device application can still work with the original device, as well as any newer version of the device application that has codes in this range (e.g., specifically to a particular serial command). If an updated devices application is not intended to be compatible with the original device version but only a new device version, then the code for the device application could be set between 10 to 1F. If the updated device is not intended to work with the original device application, then the code for the device can be set to 10 to 1F.


In certain embodiments, the key code mechanism includes a key code communicated in a pairing message exchange between two devices in the analyte monitoring system, in the same manner as described above for device serial commands accessed by a device application. In this case, the key code only needs to be included in a pairing message in order to enforce all communication restrictions between version of the device and the analyte monitoring system, since they may not communicate (e.g., except for pairing attempts) unless they are paired. This aspect can allow for full control over which device versions will work with the analyte monitoring system.


By way of example, in some embodiments, a device could be designed to accept serial commands with names $acona, $aconb, and $aconx, and the device application can issue $aconb. Moreover, the device could be designed to accept a serial command with three parameters and with five parameters.


In other embodiments, a configuration management mechanism is arranged to mechanically key the sensor to only function with a particular transmitter. For example, the sensor electrode contacts may be located in ways to allow some transmitters to properly connect and others to not. Additionally, the sensor can be incorporated into a transmitter mount that mechanically only fits the desired transmitter.


Certain embodiments allow interoperability of various sensor versions with common transmitters and receivers but enforce compatibility requirements at the receiver or other device in the system by requiring that a sensor code be entered prior to glucose calculation and display. The sensor code can be used to define a range of acceptable sensitivity of the device, and may be used to specify the sensitivity itself or contribute to the glucose calculation. Moreover, the sensor may have additional elements that identify the sensor version. Likewise, the sensor code may be used exclusively to identify the sensor version. Then the receiver device can compare the entered sensor code to a list of acceptable codes and if successful, allow glucose calculations or display. Otherwise, the receiver can notify the user that the sensor is not compatible. Furthermore, the receiver software can change algorithms or other software function dependent upon the entered sensor code.



FIG. 4 is a flow diagram illustrating steps in an embodiment for determining the compatibility of a first device 402 in an analyte monitoring system 400. The first device 402 and the second device 404 in the analyte monitoring system 400 can each include at least one of a receiver device, an analyte meter, a glucose monitor, an insulin pump, a continuous analyte monitor, a cellular phone, a personal digital assistant, a personal computer, a laptop computer, and/or a repeater unit. In certain embodiments, a first device 402 sends data related to its configuration to the second device 404 (406). The request can be sent, for example, wirelessly from the transmitter of the first device 402 to the transceiver of the second device 404. The configuration of first device 402, which can be an analyte sensor, can embody one or more various configurations that include different versions of the analyte sensor. Each of the configurations of the first device 402 can include various specifications associated therewith, such as a specific calibration factor and a software function that is used to process analyte data that is obtained by the first device 402. The analyte data can be processed using the software function at the first device 402 or one or more different devices.


Referring still to FIG. 4, the second device 404 receives the data related to the configuration of the first device 402 (408). The second device 404 then retrieves data that is related to configurations that are compatible with the analyte monitoring system 400 (410). The data related to the compatible configurations can be retrieved by the second device 404, for example, from one or more of at least one storage component of the second device 402, an internet based server, from a central server, and/or a distributed server. Next, the second device 404 compares the received data related to the configuration of the first device 402 with the retrieved data that is related to one or more configurations that are compatible with the analyte monitoring system 400 (412). The second device 404 determines if the configuration of the first device 402 is compatible with the analyte monitoring system 400, based upon the comparison of the received data related to the configuration of the first device 402 with the retrieved data related to one or more configurations compatible with analyte monitoring system 400 (414). The second device 404 annunciates or otherwise communicates an alarm to alert a user if it is determined that the first device 402 is not compatible with the analyte monitoring system 400 (416). The alarm may be at least one of an audio alarm, a vibratory alarm, and a visual alarm operatively coupled to the second device 404. If however, the first device 402 is determined to be compatible with the analyte monitoring system 400, then the first device 402 may proceed to obtain analyte data from the user.



FIG. 5 is a flow diagram illustrating steps in an embodiment for determining the compatibility of a first device 502 in an analyte monitoring system 500. The first device 502 and the second device 504 in the analyte monitoring system 500 can each include at least one of a receiver device, an analyte meter, a glucose monitor, an insulin pump, a continuous analyte monitor, a cellular phone, a personal digital assistant, a personal computer, a laptop computer, and/or a repeater unit. In certain embodiments, a first device 502 sends data related to its configuration to the second device 504 (506). The request can be sent, for example, wirelessly from the transmitter of the first device 502 to the transceiver of the second device 504. The configuration of first device 502, which can be an analyte sensor, can embody one or more various configurations that include different versions of the analyte sensor. Each of the configurations of the first device 502 can include various specifications associated therewith, such as a specific calibration factor and a software function that is used to process analyte data that is obtained by the first device 502. The analyte data can be processed using the software function at the first device 502 or one or more different devices.


Referring still to FIG. 5, the second device 504 receives the data related to the configuration of the first device 502 (508). The second device 504 then retrieves data that is related to the configurations the first device 502 may embody that are compatible with the analyte monitoring system 500 (510). The data related to the compatible configurations can be retrieved by the second device 504, for example, from one or more of at least one storage component of the second device 502, an internet based server, from a central server, and/or a distributed server. Next, the second device 504 compares the received data related to the configuration of the first device 502 with the retrieved data that is related to one or more configurations that are compatible with the analyte monitoring system 500 (512). The second device 504 determines if the configuration of the first device 502 is compatible with the analyte monitoring system 500, based upon the comparison of the received data related to the configuration of the first device 502 with the retrieved data related to one or more configurations compatible with analyte monitoring system 500 (514). Following the compatibility determination, the second device 504 communicates, to the first device 502, data related to the compatibility determination to the first device 502 (516). The data can be communicated, for example, from a transmitter of the second device 504 to a transceiver of the first device 502.


Still referring to FIG. 5, the first device 502 receives the data related to its compatibility with the analyte monitoring system 500 from the second device 504 (518) and alerts a user if it was determined by the second device 504 that the first device 502 is not compatible with the analyte monitoring system 500 (520), by annunciating or otherwise communicating an alarm. The alarm may be at least one of an audio alarm, a vibratory alarm, and a visual alarm. If the first device 502 is determined to be compatible with the analyte monitoring system 500, then the first device 502 may proceed to obtain analyte data from the user.


In another embodiment, the compatibility data can be transmitted to and subsequently received by a third device (not shown), and the third device can annunciate or otherwise communicate an alarm to alert the user if the first device 502 is determined to not be compatible with the analyte monitoring system 500.



FIG. 6 is a flow diagram illustrating steps in an embodiment for determining the compatibility of a first device 602 in an analyte monitoring system 600. The first device 602 and the second device 604 in the analyte monitoring system 600 can each include at least one of a receiver device, an analyte meter, a glucose monitor, an insulin pump, a continuous analyte monitor, a cellular phone, a personal digital assistant, a personal computer, a laptop computer, and/or a repeater unit. In certain embodiments, the first device 602 sends data related to its configuration to a second device 604 (606). The data can be sent, for example wirelessly from the transmitter of the first device 602 to the transceiver of the second device 604. The configuration of first device 602, which can be an analyte sensor, can embody one or more various configurations that include different versions of the analyte sensor. Each of the configurations of the first device 602 can include various specifications associated therewith, such as a specific calibration factor and a software function that is used to process analyte data that is obtained by the first device 602. The analyte data can be processed using the software function at the first device 602 or one or more different devices.


Referring still to FIG. 6, the second device 604 receives the data related to the configuration of the first device 602 (608). The second device 604 then retrieves data that is related to one or more compatible configurations of the first device 604 (610). In certain embodiments, the data includes software functions that correlate to the one or more compatible configurations of the first device. The data can be retrieved, for example, from one or more storage components of the second device 602, an internet based server, from a central server, and/or a distributed server. Moreover, the data related to the one or more compatible configurations of the first device 602, and the software functions correlated to the one or more compatible configurations can be stored at the same or separate locations, and can be retrieved at the same time as the compatibility data or at a different time. The second device 604 compares the received data with the retrieved data (612) and determines an appropriate software function that is correlated with the configuration of the first device 602 (614). The software function can be used to process analyte data that is received from the first device 602. The second device 604 receives analyte data that is obtained from the first device 602 (616), which can be sent, for example, wirelessly from the transmitter of the first device 602 to the transceiver of the second device 604. The second device 604 then processes the received analyte data using the determined appropriate software function (618) and displays the processed analyte data to a user (620).


In another embodiment, the second device 604 can communicate data related to the software function associated with the configuration of the first device 602 to a third device (not shown). The analyte data can be communicated from the first device 602 to the third device, and the third device can process the analyte data using the data related to the software function received from the second device 604. The third device may also display the processed analyte data to the user.


In certain embodiments of the present disclosure, a computer-implemented method for determining a compatibility of one or more devices in an analyte monitoring system includes receiving identification code data related to a configuration of a first device, retrieving information including a predetermined list of one or more acceptable identification code data that is related to one or more first device configurations that are compatible with the analyte monitoring system, comparing the received identification code data with the one or more acceptable identification codes from the retrieved predetermined list, and determining if the configuration of the first device is compatible with the analyte monitoring system, based upon the received identification code data being identified in the predetermined list of acceptable identification code data.


Certain aspects include alerting a user if it is determined that the configuration of the first device is not compatible with the analyte monitoring system.


Certain aspects include communicating data related to the determination of the first device being compatible with the analyte monitoring system of a second device.


Certain aspects include the first device communicating the data related to the compatibility of the first device to the second device using at least one key code.


Certain aspects include the data related to the compatibility to the first device communicated using at least one of a radio-identification code or a resistive code or a combination thereof.


Certain aspects include the identification code data including information related to a range of acceptable sensitivity of the first device.


Certain aspects include the identification code data including information related to a version of the first device.


Certain aspects include the user being alerted with at least one of an auditory alarm, a vibratory alarm, and a visual alarm.


Certain aspects include the first device being in fluid contact with an interstitial fluid under a skin layer of a user.


Certain aspects include determining a suitable software function for processing analyte data obtained by the first device, based upon a stored software function that corresponds to the received identification code data, wherein the software function is included in the information related to a predetermined list of one or more acceptable identification code data.


Certain aspects include receiving analyte data obtained by the first device that is related to an analyte level of a user, if it is determined that the first device is compatible with the analyte monitoring system, processing the received analyte data using the determined appropriate software function, and displaying the processed analyte data to the user.


Certain aspects include the compatibility of the first device including a key code of the first device being included in the predetermined list.


Certain aspects include the first device including at least one of a continuous analyte monitor, an analyte sensor, a receiver device, a repeater device, or an insulin pump.


In certain embodiments of the present disclosure, a computer-implemented method for determining a compatibility of one or more devices in an analyte monitoring system includes receiving identification code data related to a configuration of a first device, retrieving information including a predetermined list of one or more identification codes that are related to one or more first device configurations and one or more software functions relating to the one or more first device configurations, comparing the received identification code data with the one or more identification codes, and determining an appropriate software function for processing analyte data obtained by the first device that is related to an analyte level of a user, based upon a stored software function that corresponds to the received identification code data.


Certain aspects include the software function including an algorithm.


Certain aspects include the first device including at least one of a continuous analyte monitor, an analyte sensor, a receiver device, a repeater device, or an insulin pump.


Certain aspects include the information including the predetermined list and the one or more software functions retrieved from at least one of a storage component, an online database, a central database, and a distributed database.


Certain aspects include the information including the predetermined list and the one or more software functions retrieved from different locations.


Various other modifications and alterations in the structure and method of operation of the embodiments of the present disclosure will be apparent to those skilled in the art without departing from the scope and spirit of the present disclosure. Although the present disclosure has been described in connection with certain embodiments, it should be understood that the present disclosure as claimed should not be unduly limited to such embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.

Claims
  • 1. A computer-implemented method comprising: wirelessly transmitting, by an integrated sensor and sensor electronics assembly, data related to a configuration of the integrated sensor and sensor electronics assembly, wherein the integrated sensor and sensor electronics assembly comprises an on-body patch device configured for wireless communication with a reader device, andwherein the data comprises a sensor version of the integrated sensor and sensor electronics assembly;receiving, by the reader device the data related to the configuration of the integrated sensor and sensor electronics assembly, wherein the reader device comprises one or more processors and a memory coupled thereto, the memory storing one or more software functions for glucose monitoring;determining, by the one or more processors of the reader device, whether the integrated sensor and sensor electronics assembly is compatible with the one or more software functions by comparing the sensor version of the integrated sensor and sensor electronics assembly with a predetermined list; andselecting a software function of the one or more software functions based on the sensor version of the integrated sensor and sensor electronics assembly.
  • 2. The computer-implemented method of claim 1, further comprising alerting a user if it is determined that the integrated sensor and sensor electronics assembly is not compatible with the reader device.
  • 3. The computer-implemented method of claim 1, further comprising: wirelessly transmitting through an RF communication, by the integrated sensor and sensor electronics assembly to the reader device, monitored glucose data based on sensed glucose levels of a user.
  • 4. The computer-implemented method of claim 3, further comprising: displaying the wirelessly transmitted glucose data to the user on a display of the reader device.
  • 5. The computer-implemented method of claim 1, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes a radio-identification code.
  • 6. The computer-implemented method of claim 1, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes a resistive code.
  • 7. The computer-implemented method of claim 1, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes information related to a range of acceptable sensitivities.
  • 8. The computer-implemented method of claim 1, wherein the integrated sensor and sensor electronics assembly comprises a glucose sensor, a portion of which is configured to be transcutaneously positioned in a body of a user and to sense glucose levels of the user.
  • 9. The computer-implemented method of claim 1, wherein the predetermined list is stored on the reader device.
  • 10. The computer-implemented method of claim 1, wherein the reader device comprises a mobile phone.
  • 11. A glucose monitoring system comprising: an integrated sensor and sensor electronics assembly configured to wirelessly transmit data related to a configuration of the integrated sensor and sensor electronics assembly, wherein the integrated sensor and sensor electronics assembly comprises a glucose sensor, a portion of which is configured to be transcutaneously positioned in the body of a user and to sense glucose levels of the user, and an on-body patch device configured for wireless communication with a reader device; andwherein the data comprises a sensor version of the integrated sensor and sensor electronics assembly;a reader device comprising: a wireless receiver adapted to receive the data related to the configuration of the integrated sensor and sensor electronics assembly;one or more processors; andnon-transitory memory comprising one or more software functions stored thereon that, when executed by the one or more processors, causes the one or more processors to: determine whether the integrated sensor and sensor electronics assembly is compatible with the reader device by comparing the sensor version of the integrated sensor and sensor electronics assembly with a predetermined list; andselect a software function of the one or more software functions based on the sensor version of the integrated sensor and sensor electronics assembly.
  • 12. The glucose monitoring system of claim 11, wherein the one or more software functions stored in the non-transitory memory, when executed by the one or more processors, further causes the one or more processors to: cause an alert to be output to a user if it is determined that the integrated sensor and sensor electronics assembly is not compatible with the reader device.
  • 13. The glucose monitoring system of claim 11, wherein the integrated sensor and sensor electronics assembly is configured to wirelessly transmit, through an RF communication, monitored glucose data to the reader device, wherein the monitored glucose data is based on sensed glucose levels of a user.
  • 14. The glucose monitoring system of claim 13, wherein the reader device further comprises a display adapted to display the monitored glucose data to the user.
  • 15. The glucose monitoring system of claim 11, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes a radio-identification code.
  • 16. The glucose monitoring system of claim 11, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes a resistive code.
  • 17. The glucose monitoring system of claim 11, wherein the data related to the configuration of the integrated sensor and sensor electronics assembly includes information related to a range of acceptable sensitivities.
  • 18. The glucose monitoring system of claim 11, wherein the predetermined list is stored on the reader device.
  • 19. The glucose monitoring system of claim 11, wherein the predetermined list is retrieved from at least one of a storage component, an online database, a central database, and a distributed database.
  • 20. The glucose monitoring system of claim 11, wherein the reader device comprises a mobile phone.
RELATED APPLICATIONS

The present application is a continuation of U.S. patent application Ser. No. 15/065,604, filed Mar. 9, 2016, which is a continuation of U.S. patent application Ser. No. 13/684,085, filed Nov. 21, 2012, now U.S. Pat. No. 9,317,656, which claims the benefit of U.S. Provisional Patent Application No. 61/563,517, filed Nov. 23, 2011, the disclosures of all of which are incorporated herein by reference in their entireties for all purposes.

US Referenced Citations (647)
Number Name Date Kind
3581062 Aston May 1971 A
3926760 Allen et al. Dec 1975 A
3949388 Fuller Apr 1976 A
4036749 Anderson Jul 1977 A
4055175 Clemens et al. Oct 1977 A
4129128 McFarlane Dec 1978 A
4245634 Albisser et al. Jan 1981 A
4327725 Cortese et al. May 1982 A
4344438 Schultz Aug 1982 A
4349728 Phillips et al. Sep 1982 A
4425920 Bourland et al. Jan 1984 A
4441968 Emmer et al. Apr 1984 A
4464170 Clemens et al. Aug 1984 A
4478976 Goertz et al. Oct 1984 A
4494950 Fischell Jan 1985 A
4509531 Ward Apr 1985 A
4527240 Kvitash Jul 1985 A
4538616 Rogoff Sep 1985 A
4619793 Lee Oct 1986 A
4671288 Gough Jun 1987 A
4703756 Gough et al. Nov 1987 A
4731726 Allen, III Mar 1988 A
4749985 Corsberg Jun 1988 A
4757022 Shults et al. Jul 1988 A
4759828 Young et al. Jul 1988 A
4777953 Ash et al. Oct 1988 A
4779618 Mund et al. Oct 1988 A
4847785 Stephens Jul 1989 A
4854322 Ash et al. Aug 1989 A
4890620 Gough Jan 1990 A
4925268 Iyer et al. May 1990 A
4953552 DeMarzo Sep 1990 A
4986271 Wilkins Jan 1991 A
4995402 Smith et al. Feb 1991 A
5000180 Kuypers et al. Mar 1991 A
5002054 Ash et al. Mar 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5051688 Murase et al. Sep 1991 A
5055171 Peck Oct 1991 A
5082550 Rishpon et al. Jan 1992 A
5106365 Hernandez Apr 1992 A
5122925 Inpyn Jun 1992 A
5135004 Adams et al. Aug 1992 A
5165407 Wilson et al. Nov 1992 A
5202261 Musho et al. Apr 1993 A
5210778 Massart May 1993 A
5228449 Christ et al. Jul 1993 A
5231988 Wernicke et al. Aug 1993 A
5246867 Lakowicz et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5279294 Anderson et al. Jan 1994 A
5285792 Sjoquist et al. Feb 1994 A
5293877 O'Hara et al. Mar 1994 A
5299571 Mastrototaro Apr 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5340722 Wolfbeis et al. Aug 1994 A
5342789 Chick et al. Aug 1994 A
5356786 Heller et al. Oct 1994 A
5360404 Novacek et al. Nov 1994 A
5372427 Padovani et al. Dec 1994 A
5379238 Stark Jan 1995 A
5384547 Lynk et al. Jan 1995 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5394877 Orr et al. Mar 1995 A
5402780 Faasse, Jr. Apr 1995 A
5408999 Singh et al. Apr 1995 A
5410326 Goldstein Apr 1995 A
5411647 Johnson et al. May 1995 A
5431160 Wilkins Jul 1995 A
5431921 Thombre Jul 1995 A
5462645 Albery et al. Oct 1995 A
5472317 Field et al. Dec 1995 A
5489414 Schreiber et al. Feb 1996 A
5497772 Schulman et al. Mar 1996 A
5507288 Bocker et al. Apr 1996 A
5509410 Hill et al. Apr 1996 A
5514718 Lewis et al. May 1996 A
5531878 Vadgama et al. Jul 1996 A
5552997 Massart Sep 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569186 Lord et al. Oct 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593852 Heller et al. Jan 1997 A
5601435 Quv Feb 1997 A
5609575 Larson et al. Mar 1997 A
5628310 Rao et al. May 1997 A
5640954 Pfeiffer et al. Jun 1997 A
5653239 Pompei et al. Aug 1997 A
5665222 Heller et al. Sep 1997 A
5711001 Bussan et al. Jan 1998 A
5711861 Ward et al. Jan 1998 A
5726646 Bane et al. Mar 1998 A
5735285 Albert et al. Apr 1998 A
5748103 Flach et al. May 1998 A
5771891 Gozani Jun 1998 A
5772586 Heinonen et al. Jun 1998 A
5791344 Schulman et al. Aug 1998 A
5807375 Gross et al. Sep 1998 A
5875186 Belanger et al. Feb 1999 A
5899855 Brown May 1999 A
5914026 Blubaugh, Jr. et al. Jun 1999 A
5925021 Castellano et al. Jul 1999 A
5942979 Luppino Aug 1999 A
5951521 Mastrototaro et al. Sep 1999 A
5957854 Besson et al. Sep 1999 A
5961451 Reber et al. Oct 1999 A
5964993 Blubaugh, Jr. et al. Oct 1999 A
5965380 Heller et al. Oct 1999 A
5971922 Arita et al. Oct 1999 A
5972199 Heller et al. Oct 1999 A
5987353 Khatchatrian et al. Nov 1999 A
5995860 Sun et al. Nov 1999 A
6001067 Shults et al. Dec 1999 A
6004278 Botich et al. Dec 1999 A
6022315 Iliff Feb 2000 A
6024699 Surwit et al. Feb 2000 A
6028413 Brockmann Feb 2000 A
6049727 Crothall Apr 2000 A
6052565 Ishikura et al. Apr 2000 A
6066243 Anderson et al. May 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6091975 Daddona et al. Jul 2000 A
6091976 Pfeiffer et al. Jul 2000 A
6093172 Funderburk et al. Jul 2000 A
6096364 Bok et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6117290 Say et al. Sep 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6121611 Lindsay et al. Sep 2000 A
6122351 Schlueter, Jr. et al. Sep 2000 A
6129823 Hughes et al. Oct 2000 A
6134461 Say et al. Oct 2000 A
6141573 Kurnik et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6159147 Lichter et al. Dec 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6200265 Walsh et al. Mar 2001 B1
6212416 Ward et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6223283 Chaiken et al. Apr 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6270455 Brown Aug 2001 B1
6275717 Gross et al. Aug 2001 B1
6283761 Joao Sep 2001 B1
6284478 Heller et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6295506 Heinonen et al. Sep 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309884 Cooper et al. Oct 2001 B1
6314317 Willis Nov 2001 B1
6329161 Heller et al. Dec 2001 B1
6348640 Navot et al. Feb 2002 B1
6359270 Bridson Mar 2002 B1
6359444 Grimes Mar 2002 B1
6360888 McIvor et al. Mar 2002 B1
6366794 Moussy et al. Apr 2002 B1
6377828 Chaiken et al. Apr 2002 B1
6379301 Worthington et al. Apr 2002 B1
6418332 Mastrototaro et al. Jul 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6440068 Brown et al. Aug 2002 B1
6471689 Joseph et al. Oct 2002 B1
6478736 Mault Nov 2002 B1
6484045 Holker et al. Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6493069 Nagashimada et al. Dec 2002 B1
6498043 Schulman et al. Dec 2002 B1
6514718 Heller et al. Feb 2003 B2
6546268 Ishikawa et al. Apr 2003 B1
6551494 Heller et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558321 Burd et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560471 Heller et al. May 2003 B1
6561978 Conn et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6564105 Starkweather et al. May 2003 B2
6565509 Say et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6572542 Houben et al. Jun 2003 B1
6574490 Abbink et al. Jun 2003 B2
6576101 Heller et al. Jun 2003 B1
6577899 Lebel et al. Jun 2003 B2
6579690 Bonnecaze et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6591125 Buse et al. Jul 2003 B1
6595919 Bemer et al. Jul 2003 B2
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607509 Bobroff et al. Aug 2003 B2
6610012 Mault Aug 2003 B2
6633772 Ford et al. Oct 2003 B2
6635014 Starkweather et al. Oct 2003 B2
6648821 Lebel et al. Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6658396 Tang et al. Dec 2003 B1
6659948 Lebel et al. Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6675030 Ciurczak et al. Jan 2004 B2
6676816 Mao et al. Jan 2004 B2
6687546 Lebel et al. Feb 2004 B2
6689056 Kilcoyne et al. Feb 2004 B1
6694191 Starkweather et al. Feb 2004 B2
6695860 Ward et al. Feb 2004 B1
6702857 Brauker et al. Mar 2004 B2
6728877 Mackin Apr 2004 B2
6733446 Lebel et al. May 2004 B2
6740075 Lebel et al. May 2004 B2
6741877 Shults et al. May 2004 B1
6743635 Neel et al. Jun 2004 B2
6746582 Heller et al. Jun 2004 B2
6758810 Lebel et al. Jul 2004 B2
6770030 Schaupp et al. Aug 2004 B1
6789195 Prihoda et al. Sep 2004 B1
6790178 Mault et al. Sep 2004 B1
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6837858 Cunningham et al. Jan 2005 B2
6862465 Shults et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6881551 Heller et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6895265 Silver May 2005 B2
6923763 Kovatchev et al. Aug 2005 B1
6931327 Goode, Jr. et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6936006 Sabra Aug 2005 B2
6942518 Liamos et al. Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6958705 Lebel et al. Oct 2005 B2
6968294 Gutta et al. Nov 2005 B2
6971274 Olin Dec 2005 B2
6974437 Lebel et al. Dec 2005 B2
6990366 Say et al. Jan 2006 B2
6997907 Safabash et al. Feb 2006 B2
6998247 Monfre et al. Feb 2006 B2
6999854 Roth Feb 2006 B2
7003336 Holker et al. Feb 2006 B2
7003340 Say et al. Feb 2006 B2
7003341 Say et al. Feb 2006 B2
7015817 Copley et al. Mar 2006 B2
7016713 Gardner et al. Mar 2006 B2
7024245 Lebel et al. Apr 2006 B2
7025774 Freeman et al. Apr 2006 B2
7027848 Robinson et al. Apr 2006 B2
7027931 Jones et al. Apr 2006 B1
7041068 Freeman et al. May 2006 B2
7041468 Drucker et al. May 2006 B2
7046153 Oja et al. May 2006 B2
7052483 Woicik May 2006 B2
7056302 Douglas Jun 2006 B2
7074307 Simpson et al. Jul 2006 B2
7081195 Simpson et al. Jul 2006 B2
7092891 Maus et al. Aug 2006 B2
7098803 Mann et al. Aug 2006 B2
7108778 Simpson et al. Sep 2006 B2
7110803 Shults et al. Sep 2006 B2
7113821 Sun et al. Sep 2006 B1
7123950 Mannheimer Oct 2006 B2
7134999 Brauker et al. Nov 2006 B2
7136689 Shults et al. Nov 2006 B2
7153265 Vachon Dec 2006 B2
7155290 Von Arx et al. Dec 2006 B2
7171274 Starkweather et al. Jan 2007 B2
7179226 Crothall et al. Feb 2007 B2
7190988 Say et al. Mar 2007 B2
7192450 Brauker et al. Mar 2007 B2
7198606 Boecker et al. Apr 2007 B2
7207974 Safabash et al. Apr 2007 B2
7226442 Sheppard et al. Jun 2007 B2
7226978 Tapsak et al. Jun 2007 B2
7276029 Goode, Jr. et al. Oct 2007 B2
7278983 Ireland et al. Oct 2007 B2
7286894 Grant et al. Oct 2007 B1
7299082 Feldman et al. Nov 2007 B2
7310544 Brister et al. Dec 2007 B2
7324012 Mann et al. Jan 2008 B2
7329239 Safabash et al. Feb 2008 B2
7346766 Mackin Mar 2008 B2
7364592 Carr-Brendel et al. Apr 2008 B2
7366556 Brister et al. Apr 2008 B2
7379765 Petisce et al. May 2008 B2
7381184 Funderburk et al. Jun 2008 B2
7402153 Steil et al. Jul 2008 B2
7424318 Brister et al. Sep 2008 B2
7429258 Angel et al. Sep 2008 B2
7455663 Bikovsky Nov 2008 B2
7460898 Brister et al. Dec 2008 B2
7462264 Heller et al. Dec 2008 B2
7467003 Brister et al. Dec 2008 B2
7471972 Rhodes et al. Dec 2008 B2
7494465 Brister et al. Feb 2009 B2
7497827 Brister et al. Mar 2009 B2
7499002 Blasko et al. Mar 2009 B2
7519408 Rasdal et al. Apr 2009 B2
7583990 Goode, Jr. et al. Sep 2009 B2
7591801 Brauker et al. Sep 2009 B2
7599726 Goode, Jr. et al. Oct 2009 B2
7613491 Boock et al. Nov 2009 B2
7615007 Shults et al. Nov 2009 B2
7632228 Brauker et al. Dec 2009 B2
7635594 Holmes et al. Dec 2009 B2
7637868 Saint et al. Dec 2009 B2
7640048 Dobbles et al. Dec 2009 B2
7651596 Petisce et al. Jan 2010 B2
7651845 Doyle, III et al. Jan 2010 B2
7654956 Brister et al. Feb 2010 B2
7657297 Simpson et al. Feb 2010 B2
7697967 Stafford Apr 2010 B2
7699775 Desai et al. Apr 2010 B2
7711402 Shults et al. May 2010 B2
7713574 Brister et al. May 2010 B2
7715893 Karnath et al. May 2010 B2
7727147 Osorio et al. Jun 2010 B1
7731657 Stafford Jun 2010 B2
7736310 Taub Jun 2010 B2
7736344 Moberg et al. Jun 2010 B2
7763042 Iio et al. Jul 2010 B2
7766829 Sloan et al. Aug 2010 B2
7811231 Jin et al. Oct 2010 B2
7813809 Strother et al. Oct 2010 B2
7822454 Alden et al. Oct 2010 B1
7889069 Fifolt et al. Feb 2011 B2
7899545 John Mar 2011 B2
7914460 Melker et al. Mar 2011 B2
7938797 Estes May 2011 B2
7941200 Weinert et al. May 2011 B2
7946985 Mastrototaro et al. May 2011 B2
7972296 Braig et al. Jul 2011 B2
7976466 Ward et al. Jul 2011 B2
7978063 Baldus et al. Jul 2011 B2
8010174 Goode, Jr. et al. Aug 2011 B2
8010256 Oowada Aug 2011 B2
8192394 Estes et al. Jun 2012 B2
8255026 Al-Ali Aug 2012 B1
8282549 Brauker et al. Oct 2012 B2
8597570 Terashima et al. Dec 2013 B2
9317656 Hayter Apr 2016 B2
9721063 Hayter Aug 2017 B2
20010020124 Tamada Sep 2001 A1
20010037060 Thompson et al. Nov 2001 A1
20010037366 Webb et al. Nov 2001 A1
20010047604 Valiulis Dec 2001 A1
20020019022 Dunn et al. Feb 2002 A1
20020054320 Ogino May 2002 A1
20020095076 Krausman et al. Jul 2002 A1
20020103499 Perez et al. Aug 2002 A1
20020106709 Potts et al. Aug 2002 A1
20020111832 Judge Aug 2002 A1
20020128594 Das et al. Sep 2002 A1
20020133107 Darcey Sep 2002 A1
20020147135 Schnell Oct 2002 A1
20020161288 Shin et al. Oct 2002 A1
20020188748 Blackwell et al. Dec 2002 A1
20030005464 Gropper et al. Jan 2003 A1
20030021729 Moller et al. Jan 2003 A1
20030023461 Quintanilla et al. Jan 2003 A1
20030028089 Galley et al. Feb 2003 A1
20030060692 Ruchti et al. Mar 2003 A1
20030060753 Starkweather et al. Mar 2003 A1
20030114897 Von Arx et al. Jun 2003 A1
20030147515 Kai et al. Aug 2003 A1
20030163351 Brown Aug 2003 A1
20030016833 Gao et al. Sep 2003 A1
20030199790 Boecker et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030212379 Bylund et al. Nov 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040015102 Cummings et al. Jan 2004 A1
20040041749 Dixon Mar 2004 A1
20040054263 Moerman et al. Mar 2004 A1
20040060818 Feldman et al. Apr 2004 A1
20040063435 Sakamoto et al. Apr 2004 A1
20040064068 DeNuzzio et al. Apr 2004 A1
20040073266 Haefner et al. Apr 2004 A1
20040078215 Dahlin et al. Apr 2004 A1
20040106858 Say et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040133390 Osorio et al. Jul 2004 A1
20040135684 Steinthal et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040147872 Thompson Jul 2004 A1
20040152622 Keith et al. Aug 2004 A1
20040167801 Say et al. Aug 2004 A1
20040171921 Say et al. Sep 2004 A1
20040176672 Silver et al. Sep 2004 A1
20040204687 Mogensen et al. Oct 2004 A1
20040204868 Maynard et al. Oct 2004 A1
20040223985 Dunfiled et al. Nov 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040254433 Bandis et al. Dec 2004 A1
20040254434 Goodnow et al. Dec 2004 A1
20040260478 Schwamm Dec 2004 A1
20040267300 Mace Dec 2004 A1
20050001024 Kusaka et al. Jan 2005 A1
20050003470 Nelson et al. Jan 2005 A1
20050004494 Perez et al. Jan 2005 A1
20050027177 Shin et al. Feb 2005 A1
20050031689 Shults et al. Feb 2005 A1
20050038680 McMahon Feb 2005 A1
20050049179 Davidson et al. Mar 2005 A1
20050070774 Addison et al. Mar 2005 A1
20050090607 Tapsak et al. Apr 2005 A1
20050096511 Fox et al. May 2005 A1
20050096516 Soykan et al. May 2005 A1
20050113886 Fischell et al. May 2005 A1
20050114068 Chey et al. May 2005 A1
20050116683 Cheng et al. Jun 2005 A1
20050137530 Campbell et al. Jun 2005 A1
20050173245 Feldman et al. Aug 2005 A1
20050176136 Burd et al. Aug 2005 A1
20050182306 Sloan Aug 2005 A1
20050184153 Auchinleck Aug 2005 A1
20050187442 Cho et al. Aug 2005 A1
20050195930 Spital et al. Sep 2005 A1
20050204134 Von Arx et al. Sep 2005 A1
20050214892 Kovatchev et al. Sep 2005 A1
20050245799 Brauker et al. Nov 2005 A1
20050251033 Scarantino et al. Nov 2005 A1
20050277912 John Dec 2005 A1
20060000153 Kraft et al. Jan 2006 A1
20060001551 Kraft et al. Jan 2006 A1
20060010098 Goodnow et al. Jan 2006 A1
20060015020 Neale et al. Jan 2006 A1
20060015024 Brister et al. Jan 2006 A1
20060017923 Ruchti et al. Jan 2006 A1
20060020300 Nghiem et al. Jan 2006 A1
20060031094 Cohen et al. Feb 2006 A1
20060079740 Silver et al. Apr 2006 A1
20060091006 Wang et al. May 2006 A1
20060142651 Brister et al. Jun 2006 A1
20060154642 Scannell Jul 2006 A1
20060166629 Reggiardo Jul 2006 A1
20060173406 Haves et al. Aug 2006 A1
20060189863 Peyser et al. Aug 2006 A1
20060193375 Lee et al. Aug 2006 A1
20060222566 Brauker et al. Oct 2006 A1
20060224141 Rush et al. Oct 2006 A1
20060226985 Goodnow et al. Oct 2006 A1
20060247508 Fennell Nov 2006 A1
20060247985 Liamos et al. Nov 2006 A1
20060258929 Goode et al. Nov 2006 A1
20060272652 Stocker et al. Dec 2006 A1
20060290496 Peeters et al. Dec 2006 A1
20060293607 Alt et al. Dec 2006 A1
20070000163 Kamath et al. Jan 2007 A1
20070010950 Abensour et al. Jan 2007 A1
20070017983 Frank et al. Jan 2007 A1
20070027381 Stafford Feb 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070060869 Tolle et al. Mar 2007 A1
20070060979 Strother et al. Mar 2007 A1
20070066956 Finkel Mar 2007 A1
20070073129 Shah et al. Mar 2007 A1
20070078320 Stafford Apr 2007 A1
20070078321 Mazza et al. Apr 2007 A1
20070078322 Stafford Apr 2007 A1
20070078818 Zvitz et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070149875 Ouyang et al. Jun 2007 A1
20070173706 Neinast et al. Jul 2007 A1
20070173709 Petisce et al. Jul 2007 A1
20070173710 Petisce et al. Jul 2007 A1
20070191702 Yodfat et al. Aug 2007 A1
20070203407 Hoss et al. Aug 2007 A1
20070203539 Stone et al. Aug 2007 A1
20070203966 Brauker et al. Aug 2007 A1
20070208246 Brauker et al. Sep 2007 A1
20070228071 Kamen et al. Oct 2007 A1
20070231846 Cosentino et al. Oct 2007 A1
20070232878 Kovatchev et al. Oct 2007 A1
20070235331 Simpson et al. Oct 2007 A1
20070249922 Peyser et al. Oct 2007 A1
20070255321 Gerber et al. Nov 2007 A1
20070255348 Holtzclaw Nov 2007 A1
20080004904 Tran Jan 2008 A1
20080009692 Stafford Jan 2008 A1
20080033254 Karnath et al. Feb 2008 A1
20080039702 Hayter et al. Feb 2008 A1
20080045824 Tapsak et al. Feb 2008 A1
20080060955 Goodnow Mar 2008 A1
20080061961 John Mar 2008 A1
20080009263 Brenneman et al. Apr 2008 A1
20080083617 Simpson et al. Apr 2008 A1
20080114228 McCluskey et al. May 2008 A1
20080125636 Ward et al. May 2008 A1
20080127052 Stoker May 2008 A1
20080177149 Weinert et al. Jul 2008 A1
20080019493 Brister et al. Aug 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080197024 Simpson et al. Aug 2008 A1
20080200788 Brister et al. Aug 2008 A1
20080200789 Brister et al. Aug 2008 A1
20080200791 Simpson et al. Aug 2008 A1
20080201325 Doniger et al. Aug 2008 A1
20080208025 Shults et al. Aug 2008 A1
20080214918 Brister et al. Sep 2008 A1
20080228051 Shults et al. Sep 2008 A1
20080228054 Shults et al. Sep 2008 A1
20080228055 Sher Sep 2008 A1
20080234943 Ray et al. Sep 2008 A1
20080242961 Brister et al. Oct 2008 A1
20080242963 Essenpreis et al. Oct 2008 A1
20080254544 Modzelewski et al. Oct 2008 A1
20080262469 Brister et al. Oct 2008 A1
20080269714 Mastrototaro et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080287764 Rasdal et al. Nov 2008 A1
20080296155 Shults et al. Dec 2008 A1
20080300572 Rankers et al. Dec 2008 A1
20080306434 Dobbles et al. Dec 2008 A1
20080306435 Karnath et al. Dec 2008 A1
20080306444 Brister et al. Dec 2008 A1
20080312859 Skyggebjerg et al. Dec 2008 A1
20080319085 Wright et al. Dec 2008 A1
20090006061 Thukral et al. Jan 2009 A1
20090012377 Jennewine et al. Jan 2009 A1
20090018424 Karnath et al. Jan 2009 A1
20090030294 Petisce et al. Jan 2009 A1
20090036758 Brauker et al. Feb 2009 A1
20090036763 Brauker et al. Feb 2009 A1
20090040022 Finkenzeller Feb 2009 A1
20090043181 Brauker et al. Feb 2009 A1
20090048503 Dalal et al. Feb 2009 A1
20090054747 Fennell Feb 2009 A1
20090062633 Brauker et al. Mar 2009 A1
20090076356 Simpson et al. Mar 2009 A1
20090076360 Brister et al. Mar 2009 A1
20090082693 Stafford Mar 2009 A1
20090085873 Betts et al. Apr 2009 A1
20090088787 Koike et al. Apr 2009 A1
20090093687 Telfort et al. Apr 2009 A1
20090099436 Brister et al. Apr 2009 A1
20090124879 Brister et al. May 2009 A1
20090124964 Leach et al. May 2009 A1
20090131768 Simpson et al. May 2009 A1
20090131769 Leach et al. May 2009 A1
20090131776 Simpson et al. May 2009 A1
20090131777 Simpson et al. May 2009 A1
20090131860 Nielsen May 2009 A1
20090137886 Shariati et al. May 2009 A1
20090137887 Shariati et al. May 2009 A1
20090143659 Li et al. Jun 2009 A1
20090156924 Shariati et al. Jun 2009 A1
20090163791 Brister et al. Jun 2009 A1
20090178459 Li et al. Jul 2009 A1
20090182217 Li et al. Jul 2009 A1
20090192366 Mensinger et al. Jul 2009 A1
20090192380 Shariati et al. Jul 2009 A1
20090192722 Shariati et al. Jul 2009 A1
20090192724 Brauker et al. Jul 2009 A1
20090192745 Karnath et al. Jul 2009 A1
20090192751 Karnath et al. Jul 2009 A1
20090216100 Ebner et al. Aug 2009 A1
20090216103 Brister et al. Aug 2009 A1
20090240120 Mensinger et al. Sep 2009 A1
20090240128 Mensinger et al. Sep 2009 A1
20090240193 Mensinger et al. Sep 2009 A1
20090242399 Karnath et al. Oct 2009 A1
20090242425 Karnath et al. Oct 2009 A1
20090247855 Boock et al. Oct 2009 A1
20090247856 Boock et al. Oct 2009 A1
20090298182 Schulat et al. Dec 2009 A1
20090299155 Yang et al. Dec 2009 A1
20090299156 Simpson et al. Dec 2009 A1
20090299162 Brauker et al. Dec 2009 A1
20090299276 Brauker et al. Dec 2009 A1
20100076283 Simpson et al. Mar 2010 A1
20100093786 Watanabe et al. Apr 2010 A1
20100096259 Zhang et al. Apr 2010 A1
20100105999 Dixon et al. Apr 2010 A1
20100113897 Brenneman et al. May 2010 A1
20100141656 Krieftewirth Jun 2010 A1
20100146300 Brown Jun 2010 A1
20100152554 Steine et al. Jun 2010 A1
20100160759 Celentano et al. Jun 2010 A1
20100016853 Keenan et al. Jul 2010 A1
20100168540 Karnath et al. Jul 2010 A1
20100168541 Karnath et al. Jul 2010 A1
20100168542 Karnath et al. Jul 2010 A1
20100168543 Karnath et al. Jul 2010 A1
20100168544 Karnath et al. Jul 2010 A1
20100168545 Karnath et al. Jul 2010 A1
20100168546 Karnath et al. Jul 2010 A1
20100168657 Karnath et al. Jul 2010 A1
20100174168 Goode, Jr. et al. Jul 2010 A1
20100174266 Estes Jul 2010 A1
20100179399 Goode, Jr. et al. Jul 2010 A1
20100179402 Goode, Jr. et al. Jul 2010 A1
20100179405 Goode, Jr. et al. Jul 2010 A1
20100179408 Karnath et al. Jul 2010 A1
20100179409 Karnath et al. Jul 2010 A1
20100185065 Goode, Jr. et al. Jul 2010 A1
20100185071 Simpson et al. Jul 2010 A1
20100185072 Goode, Jr. et al. Jul 2010 A1
20100185073 Goode, Jr. et al. Jul 2010 A1
20100185074 Goode, Jr. et al. Jul 2010 A1
20100185075 Brister et al. Jul 2010 A1
20100185175 Kamen et al. Jul 2010 A1
20100198034 Thomas et al. Aug 2010 A1
20100198035 Karnath et al. Aug 2010 A1
20100198142 Sloan et al. Aug 2010 A1
20100213080 Celentano et al. Aug 2010 A1
20100217105 Yodfat et al. Aug 2010 A1
20100262201 He et al. Oct 2010 A1
20100313105 Nekoomaram et al. Dec 2010 A1
20100331642 Bruce et al. Dec 2010 A1
20110000243 Simpson et al. Feb 2011 A1
20110002745 Boock et al. Feb 2011 A1
20110024043 Boock et al. Feb 2011 A1
20110027127 Simpson et al. Feb 2011 A1
20110027453 Boock et al. Feb 2011 A1
20110028815 Simpson et al. Feb 2011 A1
20110028816 Simpson et al. Feb 2011 A1
20110031986 Bhat et al. Feb 2011 A1
20110077490 Simpson et al. Mar 2011 A1
20110112696 Yodfat et al. May 2011 A1
20110148905 Simmons et al. Jun 2011 A1
20110178461 Chong et al. Jul 2011 A1
20110208027 Wagner et al. Aug 2011 A1
20110213225 Bernstein et al. Sep 2011 A1
20110257895 Brauker et al. Oct 2011 A1
20110287528 Fern et al. Nov 2011 A1
20110320130 Valdes et al. Dec 2011 A1
20120078071 Bohm et al. Mar 2012 A1
20120108934 Valdes et al. May 2012 A1
20120165626 Irina et al. Jun 2012 A1
20120165640 Galley et al. Jun 2012 A1
20130035575 Mayou et al. Feb 2013 A1
20130235166 Jones et al. Sep 2013 A1
Foreign Referenced Citations (10)
Number Date Country
0098592 Jan 1984 EP
0127958 Dec 1984 EP
0320109 Jun 1989 EP
0390390 Oct 1990 EP
0396788 Nov 1990 EP
WO-0059370 Oct 2000 WO
WO-0152935 Jul 2001 WO
WO-0154753 Aug 2001 WO
WO-0382091 Oct 2003 WO
WO-2008001366 Jan 2008 WO
Non-Patent Literature Citations (48)
Entry
Angora Technologies, Inc. v. HTC America, Inc. [Opinion], US Court of Appeals for the Federal Circuit, Appeal No. 18-1404, Friday, Nov. 16, 2018.
Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526.
Aussedat, B., et al., “A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycemic Alarm”, Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1070.
Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics. vol. 4, No. 1, 2002, pp. 25-33.
Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.
Brooks, S. L., et al., “Development of an On-line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987, pp. 45-56.
Cass, A. E.G., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, pp. 667-671.
Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on “Wired” Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.
El-Khatib, F. H., et al., “Adaptive Closed-Loop Control Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine”, Journal of Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.
Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5 No. 5, 2003, pp. 769-779.
Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.
Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.
Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5,No. 5, 1997,pp. 709-719.
Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, p. 198.
Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients With Type 1 Diabetes?”, Diabetologia, vol. 45, 2002, pp. 250.
Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.
Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.
Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.
Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectroscopy”, Clinical Chemistry, vol. 45, No. 9, 1999,pp. 1651-1658.
McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages.
McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.
McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988,pp. 526-532.
Morbiducci, U., et al., “Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation”, Clinical Science, vol. 112, 2007, pp. 257-263.
Mougiakakou, S. G., et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference, 2005, pp. 298-301.
Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.
Pickup, J. C., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88,pp. 335-346.
Pickup, J. C., et al., “In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer”, Diabetologia, vol. 32, 1989,pp. 213-217.
Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.
Quinn, C. P., et al., “Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensors”, American Journal of Physiology, vol. 269, No. 1, 1995, E155-E161.
Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Reviews™ in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.
Sakakida, M., et al., “Development of ferrocene-mediated needle-type glucose sensor as a measure of true subcutaneous tissue glucose concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.
Sakakida, M., et al., “Ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.
Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308.
Schmidtke, D. W., et al., “Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.
Shaw, G. W., et al., “In Vitro testing of a simply constructed, highly stable glucose s ensor suitable for i mplantation in d iabetic p atients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.
Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane d esign for extending the long-life of an implantable g lucose sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.
Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.
Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.
Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982,pp. 1129-1131.
Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.
Sternberg, R., et al., “Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40.
Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261.
Turner, A.P.F., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985,pp. 85-115.
Updike, S. J., et al., “Principles of Long-term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous In vivo Monitoring, Chapter 4, 1997, pp. 117-137.
Velho, G., et al., “Strategies for calibrating a subcutaneous glucose sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.
Wilson, G. S., et al., “Progress toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.
Related Publications (1)
Number Date Country
20180046757 A1 Feb 2018 US
Provisional Applications (1)
Number Date Country
61563517 Nov 2011 US
Continuations (2)
Number Date Country
Parent 15065604 Mar 2016 US
Child 15640058 US
Parent 13684085 Nov 2012 US
Child 15065604 US